Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease

Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease

Conditions: Type 2 Diabetes; Chronic Kidney Diseases
Interventions: Diagnostic Test: Oral sodium suppression test; Diagnostic Test: Saline suppression test; Diagnostic Test: Captopril suppression test; Diagnostic Test: Dexamethasone suppression test; Diagnostic Test: Cosyntropin stimulation test
Sponsors: Brigham and Women’s Hospital
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 5, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments